Pyxis Oncology to Host Live Webcast on Updated MICVO Phase 1 Monotherapy Data Demonstrating Durable Response in 2L+ R/M HNSCC Following Late-Breaking Oral Presentation at EORTC-NCI-AACR Symposium
Updated data from a more mature October 2026 data cutoff show rapid and deep responses, with a 39% confirmed ORR, median duration of response of 9.2 months and median PFS of 6.7 months
Updated data from a more mature October 2026 data cutoff show rapid and deep responses, with a 39% confirmed ORR, median duration of response of 9.2 months and median PFS of 6.7 months
De nouveaux tableaux de bord et une vérification des documents validée par des experts offrent aux acheteurs une visibilité accrue sur les performances des fournisseurs, la conformité et la traçabilité jusqu’à l’origine De nouveaux tableaux de bord et une vérification des documents validée par des experts offrent aux acheteurs une visibilité accrue sur les performances… ...
Success Knocks Recognition Highlights CallTower's Global Growth and Leadership Across UCaaS, CCaaS, Customer Experience, and AI-Powered Communications Success Knocks Recognition Highlights CallTower's Global Growth and Leadership Across UCaaS, CCaaS, Customer Experience, and AI-Powered Communications ...